ROYCE & ASSOCIATES LP - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 151 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$6,609,000
-53.0%
58,500
-51.0%
0.04%
-48.0%
Q3 2015$14,066,000
+13.9%
119,500
-25.1%
0.08%
+44.2%
Q2 2015$12,350,000
-25.0%
159,500
-43.9%
0.05%
-16.1%
Q1 2015$16,458,000
+49.9%
284,500
-16.4%
0.06%
+63.2%
Q4 2014$10,981,000
+31.8%
340,5000.0%0.04%
+35.7%
Q3 2014$8,332,000340,5000.03%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$125,702,00041.75%
VHCP Management, LLC 1,178,474$138,718,00035.56%
Palo Alto Investors LP 2,579,154$303,592,00014.60%
Baker Brothers Advisors 4,135,412$486,779,0004.50%
APIS CAPITAL ADVISORS, LLC 23,000$2,708,0003.75%
EMORY UNIVERSITY 11,096$1,306,0003.64%
Atika Capital Management LLC 61,000$7,180,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 488,912$57,550,0002.78%
Segantii Capital Management Ltd 100,000$11,134,0002.55%
NEXT CENTURY GROWTH INVESTORS LLC 428,835$50,478,0002.10%
View complete list of ANACOR PHARMACEUTICALS INC shareholders